By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

EPIX Pharmaceuticals, Inc. 

4 Maguire Road

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-761-7600 Fax: 781-761-7632


SEARCH JOBS

EPIX Pharmaceuticals is a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform. The company has a pipeline of internally-discovered drug candidates currently in clinical development to treat diseases of the central nervous system and lung conditions. EPIX also has collaborations with leading organizations, including GlaxoSmithKline, Amgen, Cystic Fibrosis Foundation Therapeutics, and Bayer Schering Pharma AG, Germany.

For more information about EPIX, please visit the company’s website at www.epixpharma.com.

Key Statistics


Email: info@epixpharma.com
Ownership: Public

Web Site: EPIX Pharmaceuticals, Inc.
Employees: 100
Symbol: EPIX
 



Industry
Biotechnology






Company News
AMG 277 Discriminates Against S1P3 Receptor by 50-fold. S1P1 Lead Compounds Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Assets Generated by EPIX Pharmaceuticals, Inc. (EPIX) and Amgen (AMGN). 11/30/2011 9:51:59 AM
S1P1 Lead Compounds, Assets Generated by EPIX Pharmaceuticals, Inc. (EPIX) and Amgen (AMGN), Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Target Rationale for S1P1 Agonists Explained. 11/9/2011 6:16:48 AM
Bristol-Myers Squibb Company (BMY) Release: Back-Up Compounds and S1P1 Lead Compounds, Assets Generated by Bristol-Myers Squibb Company (BMY). and EPIX Pharmaceuticals, Inc. (EPIX), Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale 11/3/2011 5:50:35 AM
EPIX Pharmaceuticals, Inc. (EPIX) Release: Contractual Agreements Revealed for S1P1 Lead Compounds, AMG 369 and AMG 277, Offered for Sale at a December 8, 2011 Sealed Bid Sale 10/26/2011 6:14:36 AM
EPIX Pharmaceuticals, Inc. (EPIX) Release: S1P1 Agonists are Currently Indicated For Treatment of Multiple Sclerosis 10/18/2011 11:58:54 AM
EPIX Pharmaceuticals, Inc. (EPIX) Announces a Change in the May 28, 2010 Auction Sale of Imaging Agents to June 22, 2010 5/21/2010 11:05:56 AM
EPIX Pharmaceuticals, Inc. (EPIX) Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent 5/17/2010 10:57:50 AM
EPIX Pharmaceuticals, Inc. (EPIX) Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent 5/10/2010 11:06:31 AM
EPIX Pharmaceuticals, Inc. (EPIX) Announces the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent 5/4/2010 12:15:09 PM
EPIX Pharmaceuticals, Inc. (EPIX) Announces the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent 4/19/2010 10:36:39 AM
12345678910...
//-->